同时服用PEG化阿波血球蛋白和哈普托格洛宾可以限制微循环中的血管功能障碍,并预防急性炎症
Carlos J Munoz1, Daniela Lucas1, Cynthia R Muller1
1Department of Bioengineering, University of California, San Diego, California, United States.
Journal of applied physiology (Bethesda, Md. : 1985)
|August 15, 2024
概括
同时使用PEG-apoHb和Hp可以预防微循环功能障碍并减少炎症. 这种组合疗法提供了一种有前途的方法,可以在病理条件下缓解无细胞血红蛋白引起的并发症.
科学领域:
- 生物医学科学 生物医学科学
- 血球蛋白病变 血球蛋白病变
- 微循环研究 微循环研究
背景情况:
- 导致慢性血液溶解的病理条件释放无细胞血红蛋白 (Hb) 和自由血红素,导致并发症.
- 黑球蛋白 (Hp) 吸收二元化Hb,血素 (Hpx) 吸收自由血,但它们与改性蛋白质结合的疗效正在研究中.
- 现有的疗法旨在中和有毒的血红蛋白副产品,但需要新的策略来解决微循环功能障碍和炎症.
研究的目的:
- 客观地测量无细胞血红蛋白输注后的血管反应性和炎症概况.
- 为了评估PEG-apoHb (一种Hpx模仿剂) 与人体血衍生的Hp.
- 评估PEG-apoHb + Hp对人类Hb挑战引起的微循环和全身并发症的保护潜力.
主要方法:
- 在金色的叙利亚仓鼠内内显微镜与背面的窗户室.
- 四个实验组:对照组 (乳酸林格斯),只有PEG-apoHb,只有Hp,以及PEG-apoHb + Hp.
- 评估微血管血液动力学,系统参数,血液气体,血液参数和多器官炎症在低血压人类Hb挑战后.
主要成果:
- 同时使用PEG-apoHb + Hp可显著防止微循环中的血管收缩.
- 在PEG-apoHb + Hp组中,功能性毛细血管的数量显著增加.
- 这种组合疗法显著降低了Hb挑战后心脏和脏组织的炎症.
结论:
- 同时服用PEG-apoHb和Hp可以有效缓解由无细胞血红蛋白引起的微循环功能障碍.
- 这种治疗策略显著减少了全身炎症,特别是在心脏和脏等重要器官.
- 结合Hpx模拟器和Hp代表了一种有前途的方法来管理与病理性血液溶解相关的并发症.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
162
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
162
Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
189
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
189
Hemoglobin
3.4K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
3.4K
Oxygen Transport in the Blood
2.6K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
2.6K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
145
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
145


